期刊文献+

5-羟色胺转运体基因启动子区基因多态性与原发性早泄关系研究进展 被引量:3

Correlation of 5-hydroxytryptamine transporter gene-linked polymorphic region with lifelong premature ejaculation: Progress in studies
下载PDF
导出
摘要 早泄是现今最常见的男性性功能障碍性疾病之一,对患者及其伴侣间的性生活满意度产生严重负面影响。原发性早泄是最常见的早泄类型之一,也是目前研究的热点,其病因和发病机制尚不明确,遗传学因素被认为与原发性早泄联系紧密。研究表明5-羟色胺转运体基因在原发性早泄的发生和发展过程中发挥着重要作用。近年来,5-羟色胺转运体基因启动子区基因多态性备受人们关注。本文主要就5-羟色胺转运体基因启动子区基因多态性与原发性早泄关系的研究进行综述。 Premature ejaculation (PE), as one of the most common male sexual dysfunctions, has a serious negative impact on the sexual satisfaction of the patients and their sexual partners. Lifelong PE is a most common type and a current focus of research as well. The etiology and pathogenesis of this disease are not yet clear and genetic factors are considered to be closely related to lifelong PE. Studies show that the 5-hydroxytryptamine transporter (5-HTT) gene plays an important role in the development and progression of lifelong premature ejaculation and the 5-HTT-linked polymorphic region (5-HTTLPR) has attracted much attention in recent years. This article presents an overview on the correlation between 5-HTTLPR and lifelong PE.
作者 耿浩 张贤生 GENG hao, ZHANG Xian-sheng(Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, Chin)
出处 《中华男科学杂志》 CAS CSCD 北大核心 2018年第3期268-271,共4页 National Journal of Andrology
基金 国家自然科学基金(81571429)~~
关键词 原发性早泄 5-羟色胺转运体 基因多态性 选择性5-羟色胺再摄取抑制剂 lifelong premature ejaculation 5-hydroxytryptamine transporter gene polymorphism selective serotonin reuptakeinhibitor
  • 相关文献

参考文献8

二级参考文献70

  • 1潘寿华,谢立平.氟西汀治疗早泄的效果观察[J].临床泌尿外科杂志,2004,19(7):400-401. 被引量:11
  • 2WANG Wei-fu,CHANG Le,Suks Minhas,David J Ralph.Selective serotonin reuptake inhibitors in the treatment of premature ejaculation[J].Chinese Medical Journal,2007(11):1000-1006. 被引量:14
  • 3Jannini EA, Lenzi A. Epidemiology of premature ejaculation. Curr Opin Urol, 2005,15(6) : 399-403.
  • 4Mendels J, Camera A, Sikes C. Sertraline treatment for premature ejaculation. J Clin Psychopharmacol, 1995,15 (5) : 341- 346.
  • 5Atmaca M, Kuloglu M, Tezcan E, et al. Serum leptin levels in patients with premature ejaculation before and after citalopram treatment. BJU Int, 2003,91 (3) : 252-254.
  • 6Waldinger MD, Hengeveld MW, Zwinderman AH, et al. Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. J Clin Psychophatmacol, 1998,18 (4) : 274-281.
  • 7Safarinejad MR. Comparison of dapoxetine versus paroxetine in patients with premature ejaculation: a double-blind, placebo- controlled, fixed-dose, randomized study. Clin Neuropharmacol, 2006,29(5) : 243-252.
  • 8Yilmaz U, Tatlisen A, Turan H, et al. The effects of fluoxetine on several neurophysiological variables in patients with premature ejaculation. J Urol, 1999,161 ( 1 ) : 107-111.
  • 9Novaretti JPT, Pompeo ACL, Arap S. Selective serotonin re-uptake inhibitor in the treatment of premature ejaculation. Braz J Urol, 2002,28(2) : 116-122.
  • 10Safarinejad MR, Hosseini SY. Safety and efficacy of citalopram in the treatment of premature ejaculation: a double-blind placebocontrolled, fixed dose, randomized study. Int J Impot Res, 2006,18(2) : 164-169.

共引文献85

同被引文献34

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部